GVK Biosciences, which operates under the GVK BIO brand, is planning to expand its clinical research facility at Ahmedabad.
GVK BIO plans to add 50 new beds to the Ahmedabad facility to carry out clinical trials and start an analytical laboratory. The expansion will be carried out in the next three months.
GVK BIO, a clinical research and development organization, is part of the GVK Group. The company has facilities in Hyderabad, Gurgaon and Ahmedabad. It recently acquired the remaining 6.12 per cent stake held by Dai-ichi Karkaria in its subsidiary Inogent Laboratories on 11 July, 2014.
